Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00913913
What this trial is testing

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Dartmouth-Hitchcock Medical Center 8
Not applicableActive Not RecruitingNCT06917560
What this trial is testing

Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study

Who this might be right for
Renal CarcinomaSerologyAutoantibody
First Affiliated Hospital of Fujian Medical University 400
Early research (Phase 1)Study completedNCT04846920
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Study completedNCT02964078
What this trial is testing

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00003585
What this trial is testing

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
University of New Mexico 35
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00423332
What this trial is testing

Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AstraZeneca 105
Not applicableActive Not RecruitingNCT02735252
What this trial is testing

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Who this might be right for
Prostate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma+1 more
University of California, San Francisco 156
Early research (Phase 1)Ended earlyNCT03138538
What this trial is testing

M8891 First in Human in Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Renal Cell Carcinoma
EMD Serono Research & Development Institute, Inc. 27
Early research (Phase 1)UnknownNCT06182735
What this trial is testing

CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fudan University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07087158
What this trial is testing

IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Imbioray (Hangzhou) Biomedicine Co., Ltd. 30
Early research (Phase 1)Study completedNCT00095108
What this trial is testing

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaKidney NeoplasmsMetastases
ZymoGenetics 43
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Not applicableApproved For MarketingNCT00130897
What this trial is testing

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

Who this might be right for
Advanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT01182142
What this trial is testing

Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Kidney Cancer Research Bureau 51
Not applicableLooking for participantsNCT05184790
What this trial is testing

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Who this might be right for
Arrhythmias, CardiacBreast CancerProstatic Cancer+6 more
University of Sydney 300
Testing effectiveness (Phase 2)Ended earlyNCT00082459
What this trial is testing

Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Agenus Inc. 40
Early research (Phase 1)Ended earlyNCT06034860
What this trial is testing

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Who this might be right for
Non Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more
Molecular Templates, Inc. 15
Next Page